reported on a cumulative chart which enables the participant to identify improvement or deterioration with time (Fig 4) . In assessing the significance of the data it is usually assumed that a variance index > 2 or an s.d. > 2 suggests an unsatisfactory performance. However, this statistical procedure is such that 5% of results will always fall outside 2 s.d. no matter how much improvement has taken place. An alternative approach is to establish an acceptable limit of accuracy from results obtained by referee laboratories where the measurements are made under rigidly controlled conditions. It is also necessary to consider the practical significance when an individual measurement deviates significantly from the mean. Thus, when defining the limits of acceptability and satisfactory performance, it is essential to take into account the range of reference values ('normal range') for the particular test and the clinical significance of variation in the test. Quality control and the statistical procedures which are used are not the ultimate objective; their sole purpose is to aid in achieving the accuracy and efficiency that are the essential features of a reliable laboratory. Bull When dealing with a new controversial subject it is sometimes useful to stand back and take an overall view from some distance. I was amused to hear of the latest Martian invasion of earth. Their space-ship hovered over south England and their first report back to base was that the inhabitants of planet earth were metallic rectangular boxes. These proceeded in a regular, orderly fashion and were very colourful. However, they occasionally stopped and shook out parasites. The Martians, being intelligent, quickly recognized the difference between machines and men and further went on to report the presence of many large buildings called factories in which complicated machines were fed with raw materials at one end and produced manufactured goods at the other. There were some special factories where the raw materials were fluids from humans and the products were numerical data. Because the machines did not always work perfectly the machine-minders developed sophisticated statistical techniques to control the quality of the product. My Martians also noticed that there were other human beings who, although they received pieces of human tissue did not produce numerical data; instead they recognized visual patterns in these tissues and combined these findings with information from many different sources to produce a recommendation for action.
What, then, is the connexion between the pattern-recognizing-action-recommending human beings and the machine-minding-data-producing human beings? The answer is, I think, very little except that for historical reasons they frequently work in the same building.
Let me now leave the Martian viewpoint and come down to earth. Is there a place for quality control in any of the functions of the histopathologist? In chemical pathology, for example, we are checking the product that is produced by a technician using a machine. By analogy, in histopathology we might check the quality of the microscopical slide produced. I have heard that some non-histopathologists have suggested that this is what should be done. They advocate a checking system on artifacts and quality control on the depth and hue of staining techniques. However, any experienced pathologist will know that some laboratories produce very pale H & E sections, some produce very dark ones, some produce deep blue and some deep red. Is there a relationship between the depth or shade of colour and the usefulness of the pathologist's report? Generally speaking and within reasonable limits I would say no to this question, but someone with time to spare might like to investigate. Of course, the use of control slides in unusual, novel or tricky staining techniques is good practice and is analogous to the duplicate example of the standard quality control method. In the old Diploma of Pathology examination the twenty or thirty candidates would be asked to stain and diagnose an unstained section. The result was a spectrum of every possible hue and depth of colour. However, all the candidates were able to diagnose their own immensely variable product. I do not think, therefore, that quality control as practised by my numerate chemical and hiematological colleagues is at present of much relevance to morbid anatomy, except in a very few and limited areas.
Several times while preparing this paper I have felt that 1 should now sit down because this is the logical end of the story. However, I feel somewhat like the late Mr T B Layton, an ENT surgeon who began his lecture on 'When to remove the tonsils' by briefly listing four reasons and then declaring 'And now let us talk about something else'. The 'something else' concerns attempts to evaluate doctors' diagnostic opinions. Perhaps we should call it opinion evaluation, opinion assessment or opinion audit, or even medical audit, but I suggest that it is confusing to call it quality control. Of course, this type of assessment is applicable to any situation where complex judgments are made on inadequate evidence and could be applied equally well to pathologists, clinical doctors or even to administrators.
There are several rather different objectives in attempting to assess a doctor's performance. The noble aim is to raise professional standards and performance so that the patient receives better treatment. This is sometimes called medical audit, which has recently become much more important in the USA. However, a system of testing can also be used as an educational tool for training or continuing education or for passing an examination orreexamination to retain a licence to practise. There are also rather more sinister uses which spring all too readily to mind, and here I refer to bureaucratic and legal uses. Because of this we should proceed with some degree of caution. Another aspect which I will mention here and which easily follows on is cost effectiveness. I suggest that the more that patients pay indirectly, whether it is through insurance schemes or through the state, the more emphasis will be laid on cost effectiveness.
Turning now to various attempts that have been made to evaluate opinions in surgical pathology I will refer anyone who is interested to the very thorough and excellent article by D W Penner (1973) , entitled 'Quality Control and -Quality Evaluation in Histopathology and Cytology'. He believes that the ultimate objective in pursuing excellence in histopathology is to improve patient care and to do this there are two essential components: (1) evaluation by proficiency testing, (2) continuing education to maintain or improve standards or performance. He proceeds to describe the programme worked out by the Board of Education of the Royal College of Pathologists of Australia . Essentially the Australian adventure was to circulate to their members twelve slides together with a brief clinical summary. They carried out this exercise every year and participation was entirely voluntary. No standard nomenclature was insisted upon, the slides were nearly all of rare or very rare conditions and the judges who marked the answers were 'acknowledged experts'. A few examples of the kinds of conditions represented on the slides and the percentage correct diagnoses recorded are: Whipple's disease 96%, toruloma 93%, chromoblastomycosis 72%, alcoholic hepatitis 50%, tuberculous endometritis 40%, inflammatory fibroid polyp 13%, peritonitis arenosa 7%.
The specialist pathologists got 71 % correct on average while the trainees got only 57%. No attempt was made to determine the possible consequences of wrong diagnoses. Also no correlation was made between the judges' correct answer and peer panels. Just in passing it is of interest to note that approximately a quarter of the conditions appear in the slide collection used by one examiner in the MRCPath final. This may only mean that examples of rare but unambiguously diagnosable conditions are few.
Penner also records the experimental pilot project of the College of American Pathologists. They called it a proficiency testing programme and it consisted of asking a group of ten pathologists to select slides from their patient accession files. Starting at a specified date they were to collect the first breast lesion, the first lymph node removed for biopsy, the first epithelial skin tumour, the first abnormal liver and the first endometrial lesion encountered. Each pathologist would then have ten duplicate sections cut of this material, give the sections code numbers and a SNOP diagnosis (Systematized Nomenclature of Pathology) and send the lot to a coordinator. The group coordinator would therefore have ten sets of fifty different slides. One set would now be sent to each of the ten pathologists-who, without any clinical or pathological data, would be asked to diagnose them using SNOP nomenclature and code numbers. Thus a peer panel was automatically created and any one pathologist would be asked to diagnose fifty slides of which five would be his own material. (There were 4 American groups and one Canadian group). A consensus diagnosis was said to occur when more than 50 % of the peer panel agreed. All this, as you can see, generated masses of numerical data which were ideal for computer processing.
Some of the results were as follows. In 77 % of the slides consensus was reached. There was considerable variation in this percentage from tissue to tissue. Thus there was a consensus in 48 out of 50 skin sections but in only 29 out of 50 for the lymph glands. Not infrequently the peer panel consensus disagreed with the submitting pathologist (24 out of 193). Concurrence with the pathologist's own slides averaged approximately 80%. This finding is well in line with those of Feinstein who asked pathologists to recategorize their own diagnoses on lung cancer (Feinstein etal. 1970 ).
There are many obvious questions such as: Were enough tissues used? Are random slides the correct ones to use ? Is a 50 % consensus adequate ? Should it not be 75% or 100%? Penner suggests that with modifications this imperfect tool could make a contribution in accreditation.
We come nearer home with a contribution from Dr David Owen and Professor John Tighe (1975) . They took every tenth slide out of their 1970 collection and submitted ten of these to nine pathologists. Approximately half the pathologists were classified as 'senior', that is, had their MRCPath examination, and the remainder were 'junior' and did not have their membership. Each week one of the pathologists would act as coordinator and the slides would be projected and the written answers discussed. Consensus was taken as 100 % agreement. They recognized two grades of non-concurrence: (1) a serious error that might affect prognosis or treatment; (2) a minor error which would not have any serious clinical consequences. Consensus was not reached in 3 % of slides. Seniors made 2 % serious errors while juniors made 8 %. Seniors made 5 % minor errors while juniors made 11 %. These authors feel that this system is a valuable educational exercise, that it encourages uniformity of nomenclature and diagnostic criteria and that the results were a valuable guide for delegation of responsibility for reporting.
These three exercises, Australian, American and British, are the only ones I have found in the literature. What is surprising is that in all these studies surgical pathology is tacitly assumed to be almost entirely concerned with reading microscopical slidessometimes in complete isolation. Of course, in practice, obtaining the best answer starts with persuading the surgeon to take the best bit, not to crush it or leave it on the radiator in saline over the weekend, or not to force it into too small a bottle, &c. Quite often the gross, or macroscopic, examination and selection of the tissue for processing is vital and no-one has yet suggested how these functions can be evaluated quantitatively.
In none of these studies is any attempt made to assess whether the patients actually suffered from errors or, alternatively, would have benefited from more 'correct' diagnoses. One also wonders whether, if too much effort is directed to expertise in diagnosing slides in isolation, then other just as important or even more important aspects of the art may be overlooked.
And what of the autopsy? The mind boggles at the difficulties of quantitative objective evaluation. Indeed I was interested to read a paper entitled 'The autopsythe key to quality control in medical care' (Hasson 1972) . However, there have been a few attempts to compare and assess the value of semi-quantitative macroscopic observations on autopsy material. Guzman et al. (1972) record their work in a paper entitled 'Unaided visual estimation of atherosclerotic lesions. Biological variability compared with grading variability'. The conclusion of this was that there was some comparison between different observers but it required a great deal of effort and complicated statistical analysis. Another paper, by Jacob (1973) , from the Department of Documentation, Historic and Social Pathology, Institute of Pathology, University of Heidelberg, is entitled 'On Quality Control and Standardization of Patho-anatomic Findings within a Framework of an Epidemiological Pathology'. I need only record one item from his Table 6 , where he notes that in 100 autopsies lipoidosis or exulcerations of the arterial tree were noted 306 times by Institute A (presumably Heidelberg), but only 4 times by Institute B. I do not feel that this kind of analysis is relevant to today's discussion.
Penner also discusses quality control as applied to cytology. All I would say is that I have discussed this with several pathologists responsible for cytology and they very much fear that if quality control were introduced the chances are very high that they would find themselves doing all the cytology, and their screeners and cytology technicians would move to greener fields.
In conclusion: (1) Quality control, as applied to the quantitative data of chemical pathology, is not applicable to histopathology; there would be almost no advantage in controlling either the machine product or the technician's product.
(2) Evaluation of diagnostic opinion may have some limited application as an educational tool but no one has yet shown, or even attempted to show, that this method is in any way superior to 50 the current teaching methods such as slide seminars, &c.
(3) No one has yet shown or even attempted to show that the main objective of improving patient care is likely to be achieved by trying to impose quality control techniques on diagnostic opinions. The morbid anatomist is more than a machine into which one can feed coloured slides at one end and expect quality controlled answers to pour out at the other. He is a doctor who consults with his clinical colleagues in arriving at diagnoses and recommending action. Through the autopsy he is also the conscience of the hospital. Increasingly he is becoming the only generalist in medicine, the only doctor who sees all aspects of serious or fatal disease. An undue or over-hasty focusing onto the small area which can be controlled or assessed may be harmful to the less assessable but not less important aspects of his work. Twenty years ago, there were a few specialized virus laboratories. They made most of their own reagents, and quality control was a necessary part of laboratory practice. For example, a new batch of serum was taken into use for growing cell cultures only after extensive tests to ensure that the cells grew well in it, the susceptibility of cells to viruses was checked periodically, and antigens for serological tests were titrated against appropriate sera. The demand for more widely available diagnostic services put pressure on other laboratories to do virology. As virology became more generally practised, commercial supplies of reagents of high quality became available and it was no longer necessary or practicable for every laboratory to carry out extensive quality control procedures. When the PHLS Quality Control Committee was set up in 1971, virology was included in its terms of reference and between 50 and 60 laboratories expressed a wish to participate in virus investigations. The first objective was to find out whether it was possible to help laboratories to assess and where necessary to improve their performance of virology. It was decided to distribute simulated 'specimens' to participants as was already being done in bacteriology. 'Specimens' for virus isolation were sent out from the Public Health Laboratory, Exeter, and those for serological investigation by the Standards Laboratory for Serological Reagents.
Virus Isolation
The aim was to produce information for microbiologists on the efficiency of the methods used in their laboratories for isolation and identification of various viruses.
It was decided that two or three 'specimens', each containing a single virus, should be despatched annually to participating laboratories in a form in which they could be inserted into the routine work. Simulated throat swabs were used in distributions in 1972-4. The preparation of these swabs and the selection of transport media involved a great deal of technical work. Tests were designed to show that the specimens contained adequate numbers of viable particles of the viruses inoculated into them, and no other virus. After a pilot batch had been prepared, pairs of swabs were sent to virologists in various parts of the country. Each cultured one swab and posted the other back to Exeter for culture. If difficulties were experienced in isolating the virus further experiments were performed until satisfactory 'specimens' were produced.
'Specimens' were prepared in large batches and samples were tested before the dispatch of a distribution by post to all laboratories. At least three spare specimens were posted to distant laboratories whence they were returned by post to Exeter for examination. Report forms were designed to collect information about methods used and the time required for each stage of isolation and identification. Table 1 shows the viruses sent out in 1972, 1973 and 1974 and the numbers of participating laboratories that reported on them. Laboratories were asked to report by a date set to allow them four weeks' work on each specimen. Laboratories that took less than 15 days to isolate and identify the virus in a specimen did so correctly from 93.2% of the specimens they received, but those where 15 or more days elapsed achieved only 62.6% of correct results. Some laboratories did not report on all specimens sent to them. In Table 2 the viruses have been arranged in order of difficulty according to the numbers of labora-
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